Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1344619

registered interest
date	07/07/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether he has made an assessment of how British nationals studying abroad may add their inoculation records to the NHS App for when they return to the UK after having been vaccinated against covid-19 in the foreign country where they reside.
tabling member constituency	Wycombe
tabling member printed	Mr Steve Baker
uin	29037
answer	answer is ministerial correction date of answer 15/07/2021 answer text <p>The NHS App can only display vaccinations delivered in England. Once a British national returns from abroad, they will need to contact their general practitioner who will have guidance about what can be used to verify that a person has received a vaccine dose and ensure this is represented on their vaccination history.</p><p>There are a large variety of COVID-19 vaccines being administered worldwide. Work is ongoing, including with international partners, to determine which non-United Kingdom vaccines can be recognised.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 15/07/2021 15:33:54 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4064 label Biography information for Mr Steve Baker

1344629

registered interest
date	07/07/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether people over 40 years old are required to wait up to 12 weeks for their second covid-19 vaccine.
tabling member constituency	York Central
tabling member printed	Rachael Maskell
uin	29079
answer	answer is ministerial correction date of answer 14/07/2021 answer text <p>Since June 2021, second doses for all over 40 year olds have been administered on an eight-week interval after their first dose. All over 40 year olds who received a first dose by mid-May will be offered a second dose by 19 July.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 14/07/2021 16:05:45 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4471 label Biography information for Rachael Maskell

1344630

registered interest
date	07/07/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many people have contracted covid-19 after (a) one vaccine, (b) at least three weeks after the first vaccine, (c) two vaccines and (d) at least two weeks after the second vaccine.
tabling member constituency	York Central
tabling member printed	Rachael Maskell
uin	29080
answer	answer is ministerial correction date of answer 14/07/2021 answer text <p>Data on how many people have contracted COVID-19 after one vaccine, at least three weeks after the first vaccine, two vaccines and at least two weeks after the second vaccine is not available in the format requested.</p><p>Public Health England monitors the number of people who have tested positive for COVID-19 after they have received one or two doses of the vaccine and these data are used to calculate vaccine effectiveness estimates which are published at regular intervals.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 14/07/2021 11:51:24 answering member 4113 label Biography information for Nadhim Zahawi previous answer version 13481 answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4471 label Biography information for Rachael Maskell

1344632

registered interest
date	07/07/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the proportion of the population yet to be vaccinated who are (a) parents, (b) people working in the hospitality sector and (c) people in other groups potentially exposed to higher contact levels with people infected with covid-19.
tabling member constituency	York Central
tabling member printed	Rachael Maskell
uin	29082
answer	answer is ministerial correction date of answer 15/07/2021 answer text <p>No specific assessment has been made.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 15/07/2021 15:31:23 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4471 label Biography information for Rachael Maskell

1344635

registered interest
date	07/07/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will publish the covid-19 transmission rates for people who have had (a) one vaccine and (b) two vaccines for each of the different vaccines.
tabling member constituency	York Central
tabling member printed	Rachael Maskell
uin	29085
answer	answer is ministerial correction date of answer 12/07/2021 answer text <p>The following table shows the latest summary of evidence on vaccine effectiveness against different outcomes, including transmission, for Pfizer/BioNTech and University of Oxford/AstraZeneca as of 1 July 2021.</p><p> </p><table><tbody><tr><td rowspan="3"><p>Outcome</p></td><td colspan="4"><p>Vaccine Effectiveness</p></td></tr><tr><td colspan="2"><p>Pfizer/BioNTech</p></td><td colspan="2"><p>Oxford/AstraZeneca</p></td></tr><tr><td><p>1 dose</p></td><td><p>2 doses</p></td><td><p>1 dose</p></td><td><p>2 doses</p></td></tr><tr><td><p>Symptomatic disease</p></td><td><p>55-70%*</p></td><td><p>85-95%*</p></td><td><p>55-70%*</p></td><td><p>70-85%**</p></td></tr><tr><td><p>Hospitalisation</p></td><td><p>75-85%*</p></td><td><p>90-99%**</p></td><td><p>75-85%*</p></td><td><p>80-99%***</p></td></tr><tr><td><p>Mortality</p></td><td><p>70-80%**</p></td><td><p>95-99%**</p></td><td><p>75-85%**</p></td><td><p>75-99%***</p></td></tr><tr><td><p>Infection</p></td><td><p>55-70%**</p></td><td><p>70-90%***</p></td><td><p>60-70%***</p></td><td><p>No data</p></td></tr><tr><td><p>Transmission (secondary cases)^</p></td><td><p>45-50%***</p></td><td><p>No data</p></td><td><p>35-50%***</p></td><td><p>No data</p></td></tr></tbody></table><p> </p><p>Source: Table 3, <a href="https://eur01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.gov.uk%2Fgovernment%2Fpublications%2Fcovid-19-vaccine-surveillance-report&amp;data=04%7C01%7Ccovid19surv%40phe.gov.uk%7Cb2598e32058644d021bf08d916c0fea2%7Cee4e14994a354b2ead475f3cf9de8666%7C0%7C0%7C637565840415583246%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&amp;sdata=MFmH8qQxqsBUGSNXnO5e7tyCyPWBtYpuq%2FF3GUfu6AI%3D&amp;reserved=0" target="_blank">https://www.gov.uk/government/publications/covid-19-vaccine-surveillance-report</a></p><p> </p><p>Notes:</p><ol><li>*High Confidence - Evidence from multiple studies which is consistent and comprehensive.</li><li>**Medium Confidence - Evidence is emerging from a limited number of studies or with a moderately level of uncertainty.</li><li>***Low Confidence - Little evidence is available at present and results are inconclusive.</li><li>^effectiveness in reducing symptomatic secondary cases in households of a symptomatic index case.</li></ol><p> </p><p>Public Health England plans to publish vaccine effectiveness data for Moderna when more evidence becomes available.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 12/07/2021 15:50:18 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4471 label Biography information for Rachael Maskell

1344647

registered interest
date	07/07/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Vaccination: Birmingham
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will provide written instructions to NHS Birmingham and Solihull Clinical Commissioning Group requiring them (a) to liaise with hon. Members in the planning of community vaccinations and (b) to provide hon. Members with at least seven days notice of planned community vaccination sessions.
tabling member constituency	Birmingham, Hodge Hill
tabling member printed	Liam Byrne
uin	28969
answer	answer is ministerial correction date of answer 27/07/2021 answer text <p>There are no plans to do so. Whilst it is encouraged that clinical commissioning groups (CCGs) do liaise with local leaders and hon. Members, CCGs are autonomous organisations. As such, there is no formal guidance on the level of interaction CCGs should have with hon. Members and this should be discussed at a local level.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 27/07/2021 15:36:53 answering member 4113 label Biography information for Nadhim Zahawi previous answer version 13505 answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi answering member 4113 label Biography information for Nadhim Zahawi
tabling member	1171 label Biography information for Liam Byrne

1344650

registered interest
date	07/07/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Immunosuppression: Coronavirus
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will publish communications on the potential continued risk to immunocompromised and immunosuppressed groups who may not receive the same level of protection from the covid-19 vaccines as the general population.
tabling member constituency	Birmingham, Yardley
tabling member printed	Jess Phillips
uin	29061
answer	answer is ministerial correction date of answer 23/07/2021 answer text <p>On 12 July, we published updated guidance for the clinically extremely vulnerable, including those who are immunocompromised and immunosuppressed, in light of the lifting of restrictions on 19 July. The guidance is available at the following link:</p><p><a href="https://www.gov.uk/government/publications/guidance-on-shielding-and-protecting-extremely-vulnerable-persons-from-covid-19/guidance-on-shielding-and-protecting-extremely-vulnerable-persons-from-covid-19" target="_blank">https://www.gov.uk/government/publications/guidance-on-shielding-and-protecting-extremely-vulnerable-persons-from-covid-19/guidance-on-shielding-and-protecting-extremely-vulnerable-persons-from-covid-19</a></p><p>The Deputy Chief Medical Officer and NHS England’s National Medical Director wrote to clinicians on 16 July regarding immunosuppressed patients to provide an overview of the information available to date regarding vaccine efficacy in the immunosuppressed. This included additional information to inform conversations clinicians may have with patients who are immunosuppressed.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 23/07/2021 14:04:39 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4370 label Biography information for Jess Phillips

1344683

registered interest
date	07/07/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Travel: Coronavirus
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what the timescale is for the European Medicines Agency to approve Covishield vaccines produced at the Serum Institute of India for the EU's Green Pass.
tabling member constituency	Don Valley
tabling member printed	Nick Fletcher
uin	29161
answer	answer is ministerial correction date of answer 16/07/2021 answer text <p>Licencing applications made to the European Medicines Agency (EMA) is a matter for individual pharmaceutical companies. The timescale for a decision to approve such applications is a matter for the EMA.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 16/07/2021 09:24:05 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4832 label Biography information for Nick Fletcher

1344721

registered interest
date	07/07/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the effectiveness of covid-19 vaccines for people living with blood cancer.
tabling member constituency	Dulwich and West Norwood
tabling member printed	Helen Hayes
uin	29098
answer	answer is ministerial correction date of answer 14/07/2021 answer text <p>Virus Watch, supported by NHS Test and Trace, provides information regarding patients’ antibodies and this includes immunocompromised patients, such as those living with blood cancer as part of their cohort. The data suggests some protection against COVID-19.</p><p> </p><p>Public Health England is monitoring the effectiveness of vaccinations in clinical risk groups which will include those with immunosuppression. From the evaluation of the vaccine programme, the data shows that completion of the two dose schedule correlates well with protection from both disease and severe outcomes, including hospitalisation and death.</p><p> </p><p>The Joint Committee on Vaccination and Immunisation (JCVI) has issued interim advice about a potential COVID-19 booster programme from September 2021, starting with those most at risk from serious disease. This will include clinically extremely vulnerable adults and those who are immunosuppressed. The JCVI will continue to review evidence on the use of vaccines in those with immunosuppression and will update its advice as necessary.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 14/07/2021 16:17:04 answering member 4113 label Biography information for Nadhim Zahawi previous answer version 13462 answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4510 label Biography information for Helen Hayes

1344767

registered interest
date	07/07/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Travel: Coronavirus
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what discussions his officials are having with their counterparts in the European Commission on potential travel restrictions for UK citizens who have had the AstraZeneca vaccine produced by the Serum Institute of India.
tabling member constituency	South Shields
tabling member printed	Mrs Emma Lewell-Buck
uin	29059
answer	answer is ministerial correction date of answer 12/07/2021 answer text <p>The Government continues to engage the European Union on certification to ensure that travel between the United Kingdom and the EU is unhindered and supported by a common approach.</p><p>The Serum Institute of India (SII) manufactures Vaxzevria and Covishield and both branded vaccines are the same as the University of Oxford/AstraZeneca vaccine. All SII-made doses approved by the UK regulator, the Medicines and Healthcare products Regulatory Agency (MHRA) and administered in the UK were branded as the ’COVID-19 vaccine AstraZeneca’ which is now known commercially as ‘Vaxzevria’. The MHRA has not approved doses branded as ‘Covishield’ and none have been administered in the UK. All AstraZeneca vaccines given in the UK are the same product and appear on the NHS COVID Pass as Vaxzevria. The European Medicines Agency has authorised Vaxzevria vaccine and it is therefore recognised by the EU.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 12/07/2021 16:51:11 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4277 label Biography information for Mrs Emma Lewell-Buck